Published in AIDS Weekly, April 27th, 1998
The results were published in the April 1998 issue of the Journal of Virology (vol. 72, no. 4). PRO 542 is an antibody-like molecule that is designed to selectively target HIV and prevent the virus from infecting healthy immune system cells. PRO 542 is being developed both to treat and prevent HIV infection.
In the study, PRO 542 protected animals against infection by clinical HIV strains isolated from HIV infected individuals. The study used the hu-PBL-SCID mouse model of HIV infection, the only...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.